Isocitrate treatment of acute anemia of inflammation in a mouse model

Blood Cells, Molecules, and Diseases

Volumn 56, Issue 1, 2016, Pages 31-36

  Kim, Airie ^a   Fung, Eileen ^a   Parikh, Sona G ^a   Gabayan, Victoria ^a   Nemeth, Elizabeta ^a   Ganz, Tomas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anemia of inflammation; Erythropoiesis; Hepcidin; Iron; Isocitrate

Indexed keywords

ERYTHROPOIETIN; HEPCIDIN; ISOCITRIC ACID; LACTATE DEHYDROGENASE; SERUM AMYLOID A; SERUM AMYLOID A1; UNCLASSIFIED DRUG; IRON;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MECHANISM; ERYTHROCYTE LIFESPAN; ERYTHROPOIESIS; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; ACUTE DISEASE; ANIMAL; BLOOD; BRUCELLA ABORTUS; BRUCELLOSIS; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; INFLAMMATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOUSE;

ACUTE DISEASE; ANEMIA; ANIMALS; BRUCELLA ABORTUS; BRUCELLOSIS; DISEASE MODELS, ANIMAL; ERYTHROPOIESIS; ERYTHROPOIETIN; HEPCIDINS; INFLAMMATION; IRON; ISOCITRATES; MALE; MICE;

EID: 84963691751     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2015.09.007     Document Type: Article

References (35)

1. Weiss G., Goodnough L.T. Anemia of chronic disease. N. Engl. J. Med. 2005, 352(10):1011-1023.
2. Adamson J.W. The anemia of inflammation/malignancy: mechanisms and management. Hematol. Am. Soc. Hematol. Educ. Program 2008, 159-165.
3. Park C.H., et al. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 2001, 276(11):7806-7810.
4. Nemeth E., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306(5704):2090-2093.
5. Roy C.N., et al. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood 2007, 109(9):4038-4044.
6. De Falco L., et al. Iron refractory iron deficiency anemia. Haematologica 2013, 98(6):845-853.
7. Nemeth E., et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 2004, 113(9):1271-1276.
8. Wrighting D.M., Andrews N.C. Interleukin-6 induces hepcidin expression through STAT3. Blood 2006, 108(9):3204-3209.
9. Pietrangelo A., et al. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology 2007, 132(1):294-300.
10. Verga Falzacappa M.V., et al. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 2007, 109(1):353-358.
11. Kim A., et al. A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin. Blood 2014, 123(8):1129-1136.
12. Richardson C.L., et al. Isocitrate ameliorates anemia by suppressing the erythroid iron restriction response. J. Clin. Invest. 2013, 123(8):3614-3623.
13. Courselaud B., et al. Strain and gender modulate hepatic hepcidin 1 and 2 mRNA expression in mice. Blood Cell Mol. Dis. 2004, 32(2):283-289.
14. Ramos E., et al. Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology 2011, 53(4):1333-1341.
15. Zhang Z., et al. Ferroportin1 in hepatocytes and macrophages is required for the efficient mobilization of body iron stores in mice. Hepatology 2012, 56(3):961-971.
16. Sasu B.J., et al. Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia. Blood 2010, 115(17):3616-3624.
17. Goodnough J.B., et al. Inhibition of hepcidin transcription by growth factors. Hepatology 2012, 56(1):291-299.
18. Adams V., Myles M.H. Multiplex fluorescent immunoassay for detection of mice infected with lactate dehydrogenase elevating virus. J. Am. Assoc. Lab. Anim. Sci. 2013, 52(3):253-258.
19. Kotoh K., et al. Lactate dehydrogenase production in hepatocytes is increased at an early stage of acute liver failure. Exp. Ther. Med. 2011, 2(2):195-199.
20. Kato G.J., et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2006, 107(6):2279-2285.
21. Brugnara C. Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function. Crit. Rev. Clin. Lab. Sci. 2000, 37(2):93-130.
22. d'Onofrio G., et al. Simultaneous measurement of reticulocyte and red blood cell indices in healthy subjects and patients with microcytic and macrocytic anemia. Blood 1995, 85(3):818-823.
23. Wong S.S., et al. Detection of iron-deficiency anemia in hospitalized patients by zinc protoporphyrin. Clin. Chim. Acta 1996, 244(1):91-101.
24. Hagihara K., et al. IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system. Biochem. Biophys. Res. Commun. 2004, 314(2):363-369.
25. Libregts S.F., et al. Chronic IFN-gamma production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis. Blood 2011, 118(9):2578-2588.
26. Prince O.D., et al. Late stage erythroid precursor production is impaired in mice with chronic inflammation. Haematologica 2012, 97(11):1648-1656.
27. Cartwright G.E. The anemia of chronic disorders. Semin. Hematol. 1966, 3(4):351-375.
28. Tong W.H., Rouault T.A. Metabolic regulation of citrate and iron by aconitases: role of iron-sulfur cluster biogenesis. Biometals 2007, 20(3-4):549-564.
29. Bullock G.C., et al. Iron control of erythroid development by a novel aconitase-associated regulatory pathway. Blood 2010, 116(1):97-108.
30. Talbot A.L., et al. Aconitase regulation of erythropoiesis correlates with a novel licensing function in erythropoietin-induced ERK signaling. PLoS One 2011, 6(8).
31. Wontakal S.N., et al. A core erythroid transcriptional network is repressed by a master regulator of myelo-lymphoid differentiation. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(10):3832-3837.
32. Gardenghi S., et al. Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed brucella abortus. Blood 2014, 123(8):1137-1145.
33. Leddin M., et al. Two distinct auto-regulatory loops operate at the PU.1 locus in B cells and myeloid cells. Blood 2011, 117(10):2827-2838.
34. McIvor Z., et al. Transient expression of PU.1 commits multipotent progenitors to a myeloid fate whereas continued expression favors macrophage over granulocyte differentiation. Exp. Hematol. 2003, 31(1):39-47.
35. Nerlov C., Graf T. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 1998, 12(15):2403-2412.